Accuretic supply issue, almost 36,000 New Zealanders taking the blood pressure medicine will need to change treatments

PHARMAC

30 June 2022 - PHARMAC has updated health care professionals that supply of quinapril with hydrochlorothiazide (branded as Accuretic), from supplier Pfizer, will be disrupted due to the detection of a contaminant called nitrosamine. 

This is a global issue, with voluntary recalls happening in other countries, including in Australia, Europe, the United States of America, and Canada.

Read PHARMAC press release

Michael Wonder

Posted by:

Michael Wonder